adenosine receptor antagonists
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 17, 2010
Grant Date -
Aug 7, 2008
app pub date -
Nov 29, 2007
filing date -
Dec 1, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
adenosine receptor antagonists having the structure of Formula Iand to their use in treating mammals for various disease states, such as obesity, CNS disorders, including the “movement disorders” (Parkinson's disease, Huntington's Chorea, and catelepsy), and cerebral ischemia, excitotoxicity, cognitive and physiological disorders, depression, ADHD, and drug addiction (alcohol, amphetamine, cannabinoids, cocaine, nicotine, and opioids) and to their use in the enhancement of immune response. The invention also relates to methods for the preparation of such compounds, and to pharmaceutical compositions containing them.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully